McInerney, C. E., Ellis, H. P., Schrimpf, D., Sahm, F., Stupnikov, A., Wadsley, M., …Kurian, K. M. (2018). Genomic profiling of IDH-wildtype and IDH-mutant initial and matched recurrent glioblastomas reveals clinically actionable mutations (e.g. BRCA1/2) and resistance signatures. Neuro-Oncology, 20(3), iii215-iii216. https://doi.org/10.1093/neuonc/noy139.003